# Gentamicin for Junctional Epidermolysis Bullosa

> **NCT03526159** · PHASE1,PHASE2 · RECRUITING · sponsor: **University of Southern California** · enrollment: 6 (estimated)

## Conditions studied

- Junctional Epidermolysis Bullosa

## Interventions

- **DRUG:** Gentamicin Sulfate

## Key facts

- **NCT ID:** NCT03526159
- **Lead sponsor:** University of Southern California
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-06-01
- **Primary completion:** 2020-07-30
- **Final completion:** 2020-08-31
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2020-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03526159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03526159, "Gentamicin for Junctional Epidermolysis Bullosa". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03526159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*